CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q3 2021 Results - Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q3 2021 Results Earnings Conference Call November 10, 2021, 08:00 AM ET Company Participants Matthew Calistri - Vice President of Investor Relations Tony Coles - Chairperson & Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer Conference Call Participants Paul Matteis - Stifel Presentation Operator Good morning. Welcome to the Cerevel Therapeutics Third Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask a question during the Q&A portion of the call. Please note that this call maybe recorded. I will now hand to Mr. Matt Calistri, Vice President of Corporate Strategy and Investor Relations. Matthew Calistri Thank you. Good morning, everyone. We appreciate you joining us for our third quarter 2021 results call. On today's call, you

For further details see:

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q3 2021 Results - Earnings Call Transcript